Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection

Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity

(2016) Kaitlin Anstett et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Primary resistance to integrase strand-transfer inhibitors in Europe: Table 1.

(2015) M. Casadellà et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)

(2015) Juan Ambrosioni et al.   PLoS One

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007–2013

(2014) Joanne D Stekler et al.   ANTIVIRAL THERAPY

Update on antiretroviral treatment during primary HIV infection

(2014) Juan Ambrosioni et al.   Expert Review of Anti-Infective Therapy

Detection of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 Integrase Derived from Drug-Naive Individuals in Surabaya, Indonesia

(2013) Tomohiro Kotaki et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy

(2011) Benjamin Young et al.   ANTIVIRAL THERAPY

Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient

(2011) Sarita D Boyd et al.   ANTIVIRAL THERAPY

Acute HIV-1 Infection

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity

(2010) A. Fun et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen

(2009) J. Ghosn et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY